• USP18 Limits Pyroptosis Through GSDMD Autophagy

  2026-09-25

  Wang et al. report that USP18 limits pyroptosis by recruiting the E3 ligase MIB2 to ubiquitinate GSDMD at K168, marking it for selective autophagic degradation. The findings identify a mechanism for controlling GSDMD abundance and suggest that protein turnover, alongside proteolytic activation, can shape inflammatory cell death.

• How Tango1, Sec16 and Sec12 Define ER Exit Sites

  2026-09-25

  A Drosophila study supports a cooperative model in which Sec12, Sec16 and the animal-specific protein Tango1 make distinct contributions to ER exit site organization. Its findings position Sec12 upstream of Sec16 and Tango1 concentration, while implicating Tango1 in ER–Golgi coupling and both Tango1 and Sec16 in the recruitment or concentration of coat components.

• Hexa His Tag Peptide in Binding Assays

  2026-09-24

  Hexa His tag peptide supports cleaner recovery of His-tagged proteins during antibody-based immunoprecipitation. This article connects its competitive-elution role to AptaBLE’s emerging computational approach to protein-binding analysis—and clarifies where the two methods do and do not intersect.

• Gly-Gly-Phe-Gly: Practical Linker Workflows

  2026-09-24

  Gly-Gly-Phe-Gly (GGFG) offers a compact, sequence-defined spacer for peptide engineering and bioconjugation studies. This guide turns its linker role into a practical workflow, with small-scale screening, analytical checks, and clear limits on what the peptide alone can establish.

• Influenza Hemagglutinin (HA) Peptide for Co-IP

  2026-09-23

  Use the HA tag peptide both to detect tagged proteins and to competitively release them from anti-HA immunoprecipitation matrices. This workflow-focused guide shows how to apply it to protein-interaction studies relevant to PRKX–PD-L1 biology, while distinguishing practical assay recommendations from findings reported in the reference study.

• Influenza Hemagglutinin (HA) Peptide Workflow

  2026-09-23

  Use the Influenza Hemagglutinin (HA) Peptide as a clean competitive elution reagent for HA-tagged protein complexes, purification, and interaction studies. This workflow combines practical handling guidance with assay design insights inspired by a recent gastric cancer study of PRKX-dependent PD-L1 stabilization.

• c-Myc Peptide: Assay Control by Design

  2026-09-22

  The c-Myc Peptide is more than a blocking reagent: it is a defined competitive control for interpreting antibody-based assays. This guide connects c-Myc tag peptide displacement with rigorous assay architecture and the mechanistic lessons of selective IRF3 autophagy research.

• Fast-Dissociating Antibodies from Single-Molecule Screening

  2026-09-22

  Miyoshi et al. developed a semi-automated single-molecule TIRF assay that identifies specific monoclonal antibodies with rapid antigen dissociation directly from hybridoma cultures. The resulting Fab probes supported multiplexable super-resolution imaging and revealed rapid espin turnover within apparently stable F-actin cores of inner-ear stereocilia.

• Laminin (925-933) Protocol and QC Guide

  2026-09-21

  Laminin (925-933) is a defined Laminin B1 chain peptide for controlled cell attachment, migration, and chemotaxis workflows. This guide covers preparation, assay setup, quality controls, and interpretation boundaries; it is for research use only and should not be treated as a diagnostic, therapeutic, or universally validated metastasis model reagent.

• HBTU Workflows for Precision Peptide Synthesis

  2026-09-21

  HBTU supports rapid, mild peptide bond formation for solid-phase construction of complex enzyme-responsive sequences. This workflow connects carboxylic acid activation with practical assay design for zwitterionic peptide assemblies, while clearly separating synthesis performance from biological and translational claims.

• NEDD4L–PRMT5 in Colorectal Liver Metastasis

  2026-09-20

  This 2025 study identifies the HECT E3 ligase NEDD4L as a suppressor of colorectal cancer liver metastasis and defines PRMT5 as its degradation substrate. The findings connect NEDD4L-dependent PRMT5 turnover with reduced AKT1 arginine methylation and inhibition of AKT/mTOR signaling, providing a mechanistic framework for studying metastatic colonization.

• Selective Autophagy and IRF3 Stability in Antiviral Immunity

  2026-09-19

  The reference study identifies a CALCOCO2/NDP52-dependent selective autophagy pathway that degrades IRF3 in response to increasing viral burden. It also shows that PSMD14 preserves IRF3 by removing K27-linked ubiquitin chains at lysine 313, defining a regulatory balance between type I interferon activation and immune suppression.

• Beyond Detection: V5 Tags for Dynamic Protein Biology

  2026-09-18

  The V5 Epitope Tag Peptide is more than a Western blot reagent: it is a defined antigenic control that can strengthen recombinant protein workflows and help researchers connect endpoint immunoassays with dynamic antibody-based imaging. This article examines the mechanistic rationale, validation strategy, translational value, and practical limits of using the GKPIPNPLLGLDST peptide.

• c-Myc Peptide: Tag-Displacement Workflows

  2026-09-18

  Use the c-Myc tag peptide as a controlled competitor to test anti-c-Myc antibody specificity, release tagged fusion proteins, and improve immunoassay troubleshooting. This guide connects practical peptide handling with the reference study’s broader lesson: transcription-factor measurements become more informative when stability, binding, and pathway context are separated experimentally.

• Gly-Gly-Phe-Gly (GGFG) Peptide Guide

  2026-09-17

  Gly-Gly-Phe-Gly is a short, flexible peptide spacer used in research on drug conjugation, antibody engineering, and biomaterial design. The GGFG peptide has a reported molecular weight of 336.34 g/mol, 98% purity, and storage requirements that favor sealed, light- and moisture-protected handling at −20 °C.

8201 records 1/547 page Next 12345 下5页 Last page